These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

755 related articles for article (PubMed ID: 23666487)

  • 21. Targeting autophagy and mitophagy for mitochondrial diseases treatment.
    Villanueva Paz M; Cotán D; Garrido-Maraver J; Cordero MD; Oropesa-Ávila M; de La Mata M; Delgado Pavón A; de Lavera I; Alcocer-Gómez E; Sánchez-Alcázar JA
    Expert Opin Ther Targets; 2016; 20(4):487-500. PubMed ID: 26523761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diabetes Mellitus, Mitochondrial Dysfunction and Ca
    Belosludtsev KN; Belosludtseva NV; Dubinin MV
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32911736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitochondrial Biogenesis as a Pharmacological Target: A New Approach to Acute and Chronic Diseases.
    Whitaker RM; Corum D; Beeson CC; Schnellmann RG
    Annu Rev Pharmacol Toxicol; 2016; 56():229-49. PubMed ID: 26566156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological induction of mitochondrial biogenesis as a therapeutic strategy for the treatment of type 2 diabetes.
    Zamora M; Pardo R; Villena JA
    Biochem Pharmacol; 2015 Nov; 98(1):16-28. PubMed ID: 26212547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fucoidan Suppresses Mitochondrial Dysfunction and Cell Death against 1-Methyl-4-Phenylpyridinum-Induced Neuronal Cytotoxicity via Regulation of PGC-1α Expression.
    Han YS; Lee JH; Lee SH
    Mar Drugs; 2019 Sep; 17(9):. PubMed ID: 31480724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitochondrial response to controlled nutrition in health and disease.
    Schiff M; Bénit P; Coulibaly A; Loublier S; El-Khoury R; Rustin P
    Nutr Rev; 2011 Feb; 69(2):65-75. PubMed ID: 21294740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitochondria play a central role in estrogen-induced neuroprotection.
    Simpkins JW; Wang J; Wang X; Perez E; Prokai L; Dykens JA
    Curr Drug Targets CNS Neurol Disord; 2005 Feb; 4(1):69-83. PubMed ID: 15723615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The failure of mitochondria leads to neurodegeneration: Do mitochondria need a jump start?
    Lee J; Boo JH; Ryu H
    Adv Drug Deliv Rev; 2009 Nov; 61(14):1316-23. PubMed ID: 19716395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delivery to mitochondria: a narrower approach for broader therapeutics.
    Malhi SS; Murthy RS
    Expert Opin Drug Deliv; 2012 Aug; 9(8):909-35. PubMed ID: 22663303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitochondrial fission, fusion, and stress.
    Youle RJ; van der Bliek AM
    Science; 2012 Aug; 337(6098):1062-5. PubMed ID: 22936770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological modulation of mitochondrial calcium homeostasis.
    Arduino DM; Perocchi F
    J Physiol; 2018 Jul; 596(14):2717-2733. PubMed ID: 29319185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Power troubles in Parkinson's disease. Commentary.
    Choudary PV
    CNS Neurol Disord Drug Targets; 2011 Mar; 10(2):146. PubMed ID: 21261587
    [No Abstract]   [Full Text] [Related]  

  • 33. Mitochondrial medicine: pharmacological targeting of mitochondria in disease.
    Armstrong JS
    Br J Pharmacol; 2007 Aug; 151(8):1154-65. PubMed ID: 17519949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parkin, PINK1 and mitochondrial integrity: emerging concepts of mitochondrial dysfunction in Parkinson's disease.
    Pilsl A; Winklhofer KF
    Acta Neuropathol; 2012 Feb; 123(2):173-88. PubMed ID: 22057787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Yeast models of human mitochondrial diseases: from molecular mechanisms to drug screening.
    Schwimmer C; Rak M; Lefebvre-Legendre L; Duvezin-Caubet S; Plane G; di Rago JP
    Biotechnol J; 2006 Mar; 1(3):270-81. PubMed ID: 16897707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitochondrial Dynamics and Mitochondrial Dysfunction in Diabetes.
    Wada J; Nakatsuka A
    Acta Med Okayama; 2016 Jun; 70(3):151-8. PubMed ID: 27339203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynamin-related protein 1: A protein critical for mitochondrial fission, mitophagy, and neuronal death in Parkinson's disease.
    Feng ST; Wang ZZ; Yuan YH; Wang XL; Sun HM; Chen NH; Zhang Y
    Pharmacol Res; 2020 Jan; 151():104553. PubMed ID: 31760107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitochondria: an emerging target for therapeutics.
    Hersh SP
    Clin Pharmacol Ther; 2010 Jun; 87(6):630-2. PubMed ID: 20485316
    [No Abstract]   [Full Text] [Related]  

  • 39. The Parkinson Disease Mitochondrial Hypothesis: Where Are We at?
    Franco-Iborra S; Vila M; Perier C
    Neuroscientist; 2016 Jun; 22(3):266-77. PubMed ID: 25761946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitochondrial diseases: Drosophila melanogaster as a model to evaluate potential therapeutics.
    Foriel S; Willems P; Smeitink J; Schenck A; Beyrath J
    Int J Biochem Cell Biol; 2015 Jun; 63():60-5. PubMed ID: 25666557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.